CLINICAL_TRIALS
trial_result
· 2021-08-09
Clinical Trial Update: Reduce Bolus Injection of Bivalirudin [Phase 4]
Summary
A Phase 4 clinical trial update evaluating reduction of bolus injection of bivalirudin in acute coronary syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Han Yaling, MD | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED